Sepsis

2024 - 3 - 1

Revolutionerende Vaccine mod Sepsis Finansieret af CARB-X

CARB-X - Leukemia - Sepsis - Vaccine development

Ny vaccine mod sepsis kunne beskytte spædbørn mod E. coli infektioner. Læs mere her!

Sepsis afslører T-celle stor granulær lymfocytisk leukæmi ... Stor granulær lymfocytisk (LGL) leukæmi er en sjælden kronisk lymfoproliferativ lidelse, der stammer fra naturlige dræberceller eller T-lymfocytter.

CARB-X finansierer udviklingen af en ny vaccine mod spædbørnsepsis. Vaccinerede mødre ville give antistoffer videre til deres babyer under graviditeten og gennem modermælken for at hjælpe deres nyfødte med at bekæmpe en E. coli infektion.

Post cover
Image courtesy of "Cureus"

Sepsis Unveils T-cell Large Granular Lymphocytic Leukemia in the ... (Cureus)

Large granular lymphocytic (LGL) leukemia is a rare chronic lymphoproliferative disorder originating from natural killer cells or T lymphocytes.

Post cover
Image courtesy of "CIDRAP"

CARB-X funds development of novel vaccine for infant sepsis (CIDRAP)

Vaccinated mothers would pass the antibodies on to their babies in utero and through breastmilk to help their newborns' ward off an E coli infection. The ...

Boston U accelerator funds vaccine for infant sepsis (Becker's Hospital Review)

CARB-X funds GlyProVac to develop a maternal vaccine targeting E.coli, a leading cause of neonatal sepsis, in infants.

Post cover
Image courtesy of "PrecisionVaccinations"

$467000 Funds Maternal Vaccine to Prevent Neonatal Sepsis (PrecisionVaccinations)

Escherichia coli (E. coli) is a harmful bacteria that poses a severe threat to newborns, causing neonatal sepsis infections that can be life-threatening.

Explore the last week